Oncology Medical News about Uterine Cervical Neoplasms Radiotherapy

Your Unread Messages

See All

Tracy Hampton, PhD

FDA Update

Anti-CD20 Antibody Granted Accelerated Approval for CLL

Roberta Buell, MBA
RACs In Full Gear

Dorothy J. Schirf, MD

Technology Advances

Radiosurgery Trial Sparks Optimism for Early Lung Cancer

Sara Hartley

Cancer Science

Low Sugar Environment Promotes Oncogenic Mutations

See All Messages (38 new messages)

Hello, Suzanne Dixon
Manage E-mail | Logout

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer
Cochrane Reviews, 10/09/09

Rogers L et al. – The authors found only two trials that compared the use of radiotherapy with no radiotherapy in women with early cervical cancer who had their womb and pelvic lymph nodes removed and who were at risk of having a recurrence of their cancer. These two trials enrolled 397 women. When the authors combined the findings from these two trials, the authors found that, on average, women who received radiotherapy were between 40% and 90% less likely to have a relapse of their cancer within five years than women who did not. However, because of the low number of deaths in the trials, the authors could not confirm whether radiotherapy helped to prolong life: the authors' best estimate was that, five years after treatment, women who received radiotherapy were about 20% more likely to be alive than those who did not, but this estimate may not be very accurate and women's actual prospects could be anywhere between being three times more likely to be alive and being 60% more likely to be dead. Although women who had radiotherapy tended to have more complications than women who did not, the authors couldn't be sure whether this was due to chance rather than the radiotherapy because few women reported complications.

<< Previous
Noninvasive detection of lung cancer by analysis of exhaled...

Next >>
Amifostine for salivary glands in high-dose radioactive iodine...